Clinical Trial Update: Heparin vs Placebo for Cardiac Catheterization [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing heparin to placebo during cardiac catheterization is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Heparin (unfractionated heparin)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Cardiac Disease | Phase 3 | Status: RECRUITING